178 related articles for article (PubMed ID: 37260126)
21. Diminished CCl
Elkhamesy A; Refaat M; Gouida MSO; Alrdahe SS; Youssef MM
J Food Biochem; 2022 Apr; 46(4):e13845. PubMed ID: 34231234
[TBL] [Abstract][Full Text] [Related]
22. Herbal and Natural Dietary Products: Upcoming Therapeutic Approach for Prevention and Treatment of Hepatocellular Carcinoma.
Mandlik DS; Mandlik SK
Nutr Cancer; 2021; 73(11-12):2130-2154. PubMed ID: 33073617
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation for hepatocellular carcinoma.
Hemming AW; Nelson DR; Reed AI
Minerva Chir; 2002 Oct; 57(5):575-85. PubMed ID: 12370659
[TBL] [Abstract][Full Text] [Related]
24. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
25. Indications and limitations of liver transplantation for hepatocellular carcinoma.
Wudel LJ; Chapman WC
Surg Oncol Clin N Am; 2003 Jan; 12(1):77-90, ix. PubMed ID: 12735131
[TBL] [Abstract][Full Text] [Related]
26. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
[TBL] [Abstract][Full Text] [Related]
27. Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review.
Liu Y; Li H; Ye N; Luo CJ; Hu YY; Wu H; Gong JP
Med Sci Monit; 2019 Sep; 25():6615-6623. PubMed ID: 31479436
[TBL] [Abstract][Full Text] [Related]
28. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972
[TBL] [Abstract][Full Text] [Related]
29. Atezolizumab and bevacizumab for hepatocellular carcinoma: mechanism, pharmacokinetics and future treatment strategies.
Liu X; Lu Y; Qin S
Future Oncol; 2021 Jun; 17(17):2243-2256. PubMed ID: 33663220
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract][Full Text] [Related]
31. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
Liu K; Choi J; Le A; Yip TC; Wong VW; Chan SL; Chan HL; Nguyen MH; Lim YS; Wong GL
Aliment Pharmacol Ther; 2019 Nov; 50(9):1037-1048. PubMed ID: 31524304
[TBL] [Abstract][Full Text] [Related]
32. Treatment of inoperable hepatocellular carcinoma with immunotherapy.
Tighe SP; Iqbal U; Fernandes CT; Ahmed A
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31352386
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for hepatocellular carcinoma: current role and future opportunities.
Koller FL; Geevarghese SK; Gorden DL
Curr Pharm Des; 2007; 13(32):3265-73. PubMed ID: 18045177
[TBL] [Abstract][Full Text] [Related]
34. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
35. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.
Gay MD; Safronenka A; Cao H; Liu FH; Malchiodi ZX; Tucker RD; Kroemer A; Shivapurkar N; Smith JP
Cancer Prev Res (Phila); 2021 Jan; 14(1):17-30. PubMed ID: 33115780
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic options for intermediate-advanced hepatocellular carcinoma.
Zhang ZM; Guo JX; Zhang ZC; Jiang N; Zhang ZY; Pan LJ
World J Gastroenterol; 2011 Apr; 17(13):1685-9. PubMed ID: 21483627
[TBL] [Abstract][Full Text] [Related]
38. [Combination therapy in oncology--hepatocellular carcinoma].
Bismuth H; Fecteau A
Chirurg; 1998 Apr; 69(4):360-5. PubMed ID: 9612617
[TBL] [Abstract][Full Text] [Related]
39. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular Carcinoma.
Kusnik A; Hunter N; Rasbach E; Miethke T; Reissfelder C; Ebert MP; Teufel A
Dig Dis; 2021; 39(5):526-533. PubMed ID: 33429390
[TBL] [Abstract][Full Text] [Related]
40. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
Song MJ
World J Gastroenterol; 2015 Apr; 21(13):3843-9. PubMed ID: 25852268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
